CONSHOHOCKEN, Pa., Feb. 25, 2026 /PRNewswire/ — Suvoda, a clinical trial technology company, today announced new split budget functionality within its BudgetingCONSHOHOCKEN, Pa., Feb. 25, 2026 /PRNewswire/ — Suvoda, a clinical trial technology company, today announced new split budget functionality within its Budgeting

Suvoda advances clinical trial financial planning with support for complex multi-payee budgets

2026/02/26 00:47
4 min read

CONSHOHOCKEN, Pa., Feb. 25, 2026 /PRNewswire/ — Suvoda, a clinical trial technology company, today announced new split budget functionality within its Budgeting & Benchmarking solution, expanding how sponsors and CROs can manage complex site budget development across global studies and helping to accelerate the up-front work of clinical trials.

Budgeting & Benchmarking (formerly known as EnvisiX) is Suvoda’s software for creating and structuring clinical trial site budgets using real-time, fair market value data. It helps sponsors and CROs create budgets with confidence while eliminating manual spreadsheets and email threads with a controlled, auditable workflow that connects budget creation more directly to downstream site payment execution.

In many regions, developing a clinical trial budget is more complex than a single agreement between a sponsor and a site. Multiple entities within a single site—such as investigators, radiology departments, laboratories, or affiliated institutions—often require separate contracts and payments. Historically, this has forced sponsors to manage portions of the process outside their budgeting tools, introducing inefficiencies, compliance risks, and delays.

Suvoda’s new split budget capability enables sponsors to easily build and manage these multi-payee scenarios directly within the Budgeting & Benchmarking tool, supporting the range of global site operating models without leaving the system.

“Investigator grant budgeting is not just an administrative step in a clinical trial. It is foundational to the sponsor-site relationship and whether payments can be executed accurately and efficiently later,” said Iain Wood, Senior Product Manager at Suvoda. “When budgeting processes require manual workarounds, it can impact clinical trial timelines, quality, and ultimately how quickly sites can begin enrolling patients.”

The enhancement allows sponsors to:

  • Configure a budget structure that reflects distinct payees within a single site
  • Negotiate costs separately for investigators, departments, and external facilities involved in the clinical trial
  • Maintain a single, structured workflow for budgets across all countries and sites in a study
  • Avoid exporting data to offline tools to manage complex scenarios
  • Prepare budgets in a format that more seamlessly connects to downstream site payment configuration

This capability is increasingly important as the definition of a “site” continues to evolve. Patients may visit one hospital for treatment, another facility for specialized imaging, and an external laboratory for testing—all of which require separate contractual and financial arrangements. Split budgets allow sponsors to reflect this reality within a single, controlled budgeting process.

This enhancement builds on Suvoda’s deep experience in site payments. More than 70,000 sites in over 80 countries are configured in Greenphire Clinical Finance, Site Payments—Suvoda’s solution for paying clinical trial site costs. This gives Suvoda practical insight into what must be captured during budget negotiations to support smooth, compliant payments later in the trial lifecycle.

“Because of our depth of expertise across the site payments lifecycle, we know what information needs to be captured to achieve successful execution,” said Ashley Leuthe, Associate Vice President, Product Management at Suvoda. “This enhancement helps sponsors structure budgets in a way that better reflects how sites actually operate, which reduces rework later and supports smoother payments.”

The release marks the first in a series of planned enhancements to the Greenphire Clinical Finance, Budgeting & Benchmarking product to create a more connected, globally scalable experience from initial feasibility through to final site payment.

To learn more, visit suvoda.com and follow Suvoda on LinkedIn.

About Suvoda

Suvoda is a global clinical trial technology company with a market-leading, real-time software platform that empowers sponsors and CROs to make confident decisions and sites and patients to take calm, controlled action. Suvoda delivers interconnected, action-driven software solutions and industry-leading services and support, so that even in the most time-sensitive, mission-critical moments, life-changing studies keep moving forward. Headquartered outside Philadelphia, Suvoda also maintains offices in Portland, OR, Barcelona, Spain, Bucharest and Iasi, Romania, and Tokyo, Japan. The company maintains customer satisfaction scores that consistently exceed the technology industry average, contributing to the company being selected by trial sponsors and CROs to support more than 2000 trials across more than 95 countries. Suvoda recently merged with Greenphire, a leading provider of clinical trial financial management and patient support tools.

CONTACT: 
Robin Abadía 
Director, External Communications 
[email protected]

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/suvoda-advances-clinical-trial-financial-planning-with-support-for-complex-multi-payee-budgets-302693505.html

SOURCE Suvoda LLC

Market Opportunity
Cros Logo
Cros Price(CROS)
$0.00001585
$0.00001585$0.00001585
+2.85%
USD
Cros (CROS) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

ROKFORM Launches Rugged Case and Screen Protectors for Samsung Galaxy S26

ROKFORM Launches Rugged Case and Screen Protectors for Samsung Galaxy S26

Military-grade drop protection, pocket-friendly design, MAGMAX™ and RokLock™ mounting IRVINE, Calif., Feb. 25, 2026 /PRNewswire/ — ROKFORM today launched the Rugged
Share
AI Journal2026/02/26 04:16
Academic Publishing and Fairness: A Game-Theoretic Model of Peer-Review Bias

Academic Publishing and Fairness: A Game-Theoretic Model of Peer-Review Bias

Exploring how biases in the peer-review system impact researchers' choices, showing how principles of fairness relate to the production of scientific knowledge based on topic importance and hardness.
Share
Hackernoon2025/09/17 23:15
England’s Titanic Hitters Cruise Past Ireland In First T20 At Malahide

England’s Titanic Hitters Cruise Past Ireland In First T20 At Malahide

The post England’s Titanic Hitters Cruise Past Ireland In First T20 At Malahide appeared on BitcoinEthereumNews.com. DUBLIN, IRELAND – SEPTEMBER 17: Phil Salt of England hits out for six runs watched by Ireland wicketkeeper Lorcan Tucker during the first T20 International match between Ireland and England at Malahide Cricket Club on September 17, 2025 in Dublin, Ireland. (Photo by Gareth Copley/Getty Images) Getty Images England continued their brutal form in T20 internationals after they beat Ireland on Wednesday in the first of a three-match series. A trip across the Irish sea was a gentle introduction for stand-in captain Jacob Bethell as his side completed a comprehensive four-wicket win over the Green and Whites within the attractive environment of Malahide Castle and Gardens. England have now scored over 500 runs in the last two T20s. They mauled South Africa at Manchester last Tuesday, recording the highest score by a Full Member nation in the format. Phil Salt, who belted 141 at Old Trafford, fell 11 runs short of another century in his quest to be the best T20 batter in the world. Salt swiped his bat against his pad in anger as he walked off, but he has smashed a combined 12 sixes and 25 fours in those knocks. Ireland had batted well, scoring 25 boundaries after a relatively subdued powerplay. Lorcan Tucker averages over 40 in Test cricket, and his multi-format skills had a breezy outing here. The wicketkeeper hit a splendid 55 as he put on a stand of 123 with Harry Tector, who made 63. The only black mark against England was the bowling effort. Adil Rashid suffered more than usual in the truncated series against the Proteas, and he chucked in some ropey deliveries in North Dublin too. Jamie Overton has taken himself out of red-ball selection, but he was wayward in length. Sam Curran, England’s bits and pieces specialist, didn’t have his…
Share
BitcoinEthereumNews2025/09/18 07:53